Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Azienda Ospedaliera Universitaria Federico II - "Policlinico"

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Azienda Ospedaliera Universitaria Federico II - "Policlinico" is one of the largest and most prominent teaching hospitals in Southern Italy. It operates as an integral arm of the public Italian National Health Service while serving as the primary clinical training site for the School of Medicine and Surgery at the historic University of Naples Federico II. The hospital functions as an internationally recognized center of excellence and a key member of multiple European Reference Networks (ERN), holding particular regional and national expertise in neuromuscular diseases (such as ALS), rare endocrine diseases, oncology, cardiology, and inherited metabolic disorders.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Government hospital
Source: Trial-derived.
93Total Trials
Source: Trial-derived.
21Recruiting Trials
Source: Trial-derived.
49Active Trials
Source: Trial-derived.
35Completed Trials
Source: Trial-derived.
179Unique Conditions
Source: Trial-derived.
95Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (5)Source: Trial-derived. Coronary Artery Disease (4)Source: Trial-derived. Multiple Sclerosis (4)Source: Trial-derived. Atrial Fibrillation (3)Source: Trial-derived. Cystic Fibrosis (3)Source: Trial-derived. Heart Failure (3)Source: Trial-derived. Metastatic Breast Cancer (3)Source: Trial-derived. Renal Insufficiency (3)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (10)Source: Trial-derived. Federico II University (6)Source: Trial-derived. Bayer (4)Source: Trial-derived. Daiichi Sankyo (4)Source: Trial-derived. Fondazione Policlinico Universitario Agostino Gemelli IRCCS (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Consorzio Oncotech (3)Source: Trial-derived. MicroPort CRM (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. CT Scan
Source: AI-inferred. Cardiac device interrogation and programming
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Flow Cytometry
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Nine-hole peg testing
Source: AI-inferred. Exophthalmometry (proptosis measurement)
Source: AI-inferred. Plasma lyso-Gb3 and Gb3 biomarker testing
Source: AI-inferred. Timed 25-foot walk testing
Source: AI-inferred. Automated office blood pressure (AOBP) measurement
Source: AI-inferred. Blood p-tau217 biomarker testing
Source: AI-inferred. Cardiac stress testing
Source: AI-inferred. Cytogenetic metaphase analysis